Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine. - Wikidata - awgldk - TriplyDB

Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.

Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.

http://www.wikidata.org/entity/Q37420192

about

Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents Immune Mechanisms in Myelodysplastic Syndrome Epigenetic therapy in gastrointestinal cancer: the right combination Epigenetics in non-small cell lung cancer: from basics to therapeutics Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Recent Advances in Immunotherapy in Metastatic NSCLC Epigenetic Therapeutics: A New Weapon in the War Against Cancer PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy The impact of the Cancer Genome Atlas on lung cancer.New strategies in lung cancer: epigenetic therapy for non-small cell lung cancer C2c: turning cancer into chronic disease Molecular pathways and therapeutic targets in lung cancer Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine.Epigenetic Strategies to Boost Cancer Immunotherapies.DNA methylation modifications associated with chronic fatigue syndrome.BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression.Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells.Nivolumab in NSCLC: latest evidence and clinical potential Gene body methylation can alter gene expression and is a therapeutic target in cancer.Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study.Augmenting antitumor immune responses with epigenetic modifying agents.Does vaccine-primed pancreatic cancer offer better candidates for immune-based therapies?Molecularly targeted therapies in non-small-cell lung cancer annual update 2014 Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer Hypomethylation and up-regulation of PD-1 in T cells by azacytidine in MDS/AML patients: A rationale for combined targeting of PD-1 and DNA methylation.Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies.Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.Underexpression of Specific Interferon Genes Is Associated with Poor Prognosis of Melanoma Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells.Modulation of EZH2 Expression by MEK-ERK or PI3K-AKT Signaling in Lung Cancer Is Dictated by Different KRAS Oncogene Mutations Isoform switching and exon skipping induced by the DNA methylation inhibitor 5-Aza-2'-deoxycytidine.Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells.Combining targeted therapy with immunotherapy. Can 1+1 equal more than 2?Vitamin C increases viral mimicry induced by 5-aza-2'-deoxycytidine.

P2860

Q26738359-5E66F63D-16A0-47AF-A743-75190B5FE0CE Q26742047-04FAC8E2-597B-4AC9-8CC3-15C608093A0D Q26743743-A4E9FF03-730C-40A8-8D3B-94E84BF56C1C Q26744089-C33DBB2D-BF68-4205-BF68-F8454F27D837 Q26744212-075C24FD-F50D-4FB2-854D-C8AB917D565F Q26744500-8D235B38-3E07-4592-93F6-7E28603B4E65 Q26745709-6169F755-8ADF-411D-8140-74A515ACB7BC Q26749113-22506641-003B-40AD-A81F-D087435AA7B2 Q26780387-D5CF0A22-B5EA-45F7-8913-7A70A04C7C4A Q28069323-8AF28474-8644-4094-A037-C6C69EB2156B Q28072370-46FF60C3-EE75-468D-B2A0-9FCA6B73CF75 Q28075712-BA906620-6911-49ED-9FE7-422BCDD57067 Q28076473-627A1956-4100-4691-81D2-3FD087B99769 Q28084190-8841066C-2509-46BF-8C14-9F80F0C7DB93 Q28236190-E4A9C081-BF11-4E0B-88B7-326DB0EC952A Q28657973-7FCDEE7D-6C71-40DE-B52E-19CDCE24172B Q33688872-4D80D242-B9A1-4EB7-A6CB-1ED535E96963 Q33823065-A5934888-E449-4CDC-BEF3-C8A0F56BA6C5 Q33838340-6090FA22-D627-4F67-967A-51D7510543F9 Q34027879-D110F4D9-6286-4B55-9381-AD4F43849F1B Q34047394-56A6F6B2-2ADA-4A24-A83F-48F26E68E0C7 Q34060558-D4E3EF54-5C9A-48D1-A740-346AE013D690 Q34466452-A72FE332-1A4E-49F0-9A74-C3EC9BF8C2C9 Q34471361-7FFC0A80-327B-44AC-A870-4356EC639B2D Q34547465-0F953A2B-696B-47C9-8D5B-E9ED3D0F4DF1 Q35048054-4166C904-C14C-4A93-A38B-40A285C74669 Q35077467-0897FB53-9E06-4D6D-B068-F18EEE53D33D Q35136424-94BC2DB0-9766-4A2D-8338-1444AE0C8296 Q35238397-49ACD5A8-72C6-4A85-92C8-37E61AFA7171 Q35832463-135D1B23-2AF5-4F7D-B203-783A900E079A Q35897592-F05E06E4-E813-4E5C-B6E1-C64E102F311C Q36015063-B95D8160-1363-4094-8702-2D6C0E5C88F8 Q36225879-76505B0C-6542-404E-9E27-36799C2F87FC Q36257430-CB278816-741A-47E8-AEA3-8D16D0639039 Q36407481-2FC04948-4BD4-481F-8F93-E4823DAD2822 Q36535735-823DB9B9-4EA3-46E0-B397-A37CCC1A6D45 Q36810277-2F6ED6B3-45FC-4B17-AD1C-C382D4A29AB0 Q36946516-41BD448E-B603-4372-89FC-F7D9F16ABC62 Q37066925-F659D8CA-9842-4527-BE36-456BA849B03D Q37264298-09B44137-0696-449C-A093-6213C52AF568

P2860

Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.

http://www.wikidata.org/entity/Q37420192

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.

@en

Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.

@nl

type

label

Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.

@en

Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.

@nl

prefLabel

Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.

@en

Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.

@nl

P1433

Q37420192-F6D7E98F-6D23-42FC-AED4-E2EC32355E4C

P1476

Q37420192-4A444E19-6F2E-4304-A9F3-DE5E53C1FDD7

P2093

Q37420192-0FCC7671-DB85-4835-A7A8-B4DB6986BB80

Q37420192-2EE5063A-7821-43A2-B383-0ED5743A1E0E

Q37420192-315BADA7-CC80-4D9C-B579-8012B938D12C

Q37420192-35A1FA79-CABA-4794-B5B7-FE8FC237C7B0

Q37420192-4AF85B2B-D32E-48B2-88BE-FAAE0AF28375

Q37420192-4CE02EA2-23E0-41BA-B594-E805927ECDF0

Q37420192-5C642735-B1AA-47F2-B619-895448D6E4C4

Q37420192-67D18BB1-347E-47F8-9080-AA007308283B

Q37420192-6EFC32EC-4B9A-4C55-8DDB-0558C5FB1E38

Q37420192-7987758D-6176-4351-86EC-A70C02768CCA

P2860

Q37420192-0C0F5CF7-E44E-4DB7-AB2B-F703611A4135

Q37420192-0DBC4B9A-398A-407C-AE00-3F716BD7B613

Q37420192-1B160CBC-FDDB-4E01-9A83-23D05E9866CE

Q37420192-22E8D57D-607C-4969-87BA-11849EC51B38

Q37420192-296945E0-FE0B-49EF-AB87-8EA41FD719EE

Q37420192-357FC6C6-0CEF-49BE-9437-38D111939171

Q37420192-3FA3BD17-5111-414A-80B9-9500B66D57FE

Q37420192-44A24617-2FCA-40C0-A78D-3D11B1450AD1

Q37420192-4551538D-357C-4A2E-85E2-E8F8DEECE742

Q37420192-477F63FC-820B-4747-AAB2-53CDBE9FC555

P304

Q37420192-3208FA89-0220-45BE-A443-7FC818586FF0

P31

Q37420192-65AAA7C8-2A5B-4333-95B9-983A82840406

P356

Q37420192-4D7EC8ED-F494-4410-96DE-48235227902C

P407

Q37420192-B7141E5F-8B63-4BB2-A2DA-3BBE164BA88F

P433

Q37420192-E494FB7C-90A2-430A-A1F9-E231B13E112F

P478

Q37420192-3568DFE8-F063-4B47-87F3-98E01BE25570

P50

Q37420192-0D751863-2587-451F-B2A6-4A560E2904DC

Q37420192-35EF6E5F-66EC-4A61-80B7-449DF746F3C8

P577

Q37420192-3E820618-DB6A-4270-8327-A2B658BAABB1

P5875

Q37420192-BB5B5E5E-44B8-46F8-AD7B-381F4C599B18

P698

Q37420192-F1F0D58D-F128-40E1-A54E-EEB7D2839C18

P932

Q37420192-10A3E883-BBDC-45CA-A274-A19513F4032B

P356

ONCOTARGET.1542

P1433

P1476

Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine.

@en

P2093

Charles M Rudin

http://www.w3.org/2001/XMLSchema#string

Cynthia A Zahnow

http://www.w3.org/2001/XMLSchema#string

Daniel J Weisenberger

http://www.w3.org/2001/XMLSchema#string

Drew Pardoll

http://www.w3.org/2001/XMLSchema#string

Frank Vendetti

http://www.w3.org/2001/XMLSchema#string

Helai P Mohammad

http://www.w3.org/2001/XMLSchema#string

Janis M Taube

http://www.w3.org/2001/XMLSchema#string

John Wrangle

http://www.w3.org/2001/XMLSchema#string

Julie R Brahmer

http://www.w3.org/2001/XMLSchema#string

Keith Easton

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Natural selection of tumor variants in the generation of "tumor escape" phenotypes

Mammalian autophagy: core molecular machinery and signaling regulation

An atlas of combinatorial transcriptional regulation in mouse and man

DNA methylation screening identifies driver epigenetic events of cancer cell survival

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

INTERFEROME: the database of interferon regulated genes

Reactome: a knowledgebase of biological pathways

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

P304

2067-2079

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.1542

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Hariharan Easwaran

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258102921

http://www.w3.org/2001/XMLSchema#string

P698

24162015

http://www.w3.org/2001/XMLSchema#string

P932

3875770

http://www.w3.org/2001/XMLSchema#string